Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.21% |
| 2 | Technology | 11.19% |
| 3 | Healthcare | 7.18% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Financials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
American Tower
AMT
$81.9B
| $4.36M | ﹤0.01% |
19,400
+17,200
| +782% | +$4M |
|
2527
Foghorn Therapeutics
FHTX
$357M
| $4.36M | ﹤0.01% |
+214,862
| New | +$4.12M |
|
2528
Amerant Bancorp
AMTB
$1.13B
| $4.35M | ﹤0.01% |
+286,325
| New | +$3.71M |
|
2529
Sprott Physical Silver Trust
PSLV
$14.1B
| $4.35M | ﹤0.01% |
+465,742
| New | +$4M |
|
2530
PUT
Novavax
NVAX
$1.49B
| $4.35M | ﹤0.01% |
+39,000
| New | +$4.15M |
|
2531
Gartner
IT
$12.5B
| $4.33M | ﹤0.01% |
27,029
-8,493
| -24% | -$1.22M |
|
2532
BioLife Solutions
BLFS
$1.79B
| $4.32M | ﹤0.01% |
108,387
-403,429
| -79% | -$13.8M |
|
2533
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
| $4.32M | ﹤0.01% |
64,000
+800
| +1% | +$50.9K |
|
2534
Gyre Therapeutics
GYRE
$697M
| $4.32M | ﹤0.01% |
91,191
-35,467
| -28% | -$1.54M |
|
2535
Antero Midstream
AM
$10.6B
| $4.31M | ﹤0.01% |
559,242
+457,434
| +449% | +$3.1M |
|
|
AL
2536
DELISTED
Air Lease Corp
AL
| $4.31M | ﹤0.01% |
97,028
+64,774
| +201% | +$2.32M |
|
2537
Artivion
AORT
$1.31B
| $4.31M | ﹤0.01% |
182,533
-69,865
| -28% | -$1.42M |
|
|
OACB
2538
CALL
DELISTED
Oaktree Acquisition Corp. II
OACB
| $4.3M | ﹤0.01% |
+410,000
| New | +$4.16M |
|
2539
Mueller Industries
MLI
$14B
| $4.29M | ﹤0.01% |
489,056
+285,288
| +140% | +$2.28M |
|
|
STLNW
2540
CALL
Starling Oncology Warrant
STLNW
| $4.29M | ﹤0.01% |
397,450
| – | – |
|
2541
nCino
NCNO
$2.47B
| $4.28M | ﹤0.01% |
59,144
+38,079
| +181% | +$2.94M |
|
2542
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $4.28M | ﹤0.01% |
69,422
-60,668
| -47% | -$3.76M |
|
2543
Glaukos
GKOS
$10.7B
| $4.27M | ﹤0.01% |
+56,710
| New | +$3.58M |
|
|
CLVS
2544
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.27M | ﹤0.01% |
889,023
+767,531
| +632% | +$3.88M |
|
|
HONE
2545
DELISTED
HarborOne Bancorp
HONE
| $4.27M | ﹤0.01% |
392,826
+207,961
| +112% | +$2.05M |
|
2546
State Street Energy Select Sector SPDR ETF
XLE
$41.1B
| $4.26M | ﹤0.01% |
224,724
+2,504
| +1% | +$43.2K |
|
2547
Airbnb
ABNB
$113B
| $4.26M | ﹤0.01% |
+29,006
| New | +$4.28M |
|
2548
Altimmune
ALT
$599M
| $4.25M | ﹤0.01% |
377,188
+98,945
| +36% | +$1.17M |
|
2549
Heron Therapeutics
HRTX
$62.4M
| $4.23M | ﹤0.01% |
200,031
-4,207
| -2% | -$73.1K |
|
2550
PUT
Labcorp
LH
$27.3B
| $4.23M | ﹤0.01% |
24,211
+18,391
| +316% | +$3.18M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $25B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 52% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.